Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Myocardial Layer-Specific Longitudinal Strain for Identification of the Culprit Vessel in Elderly Patients With NSTE-ACS.

Echocardiography (Mount Kisco, N.Y.)·2026

Same author

Sex-specific Evaluation of Ventricular Ejection Fraction and End-Systolic Volume Applied to Cardiac Resynchronization Therapy.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023

Same author

[A critical analysis of ejection fraction].

Revista medica de Chile·2022

Same author

Ventricular and Atrial Ejection Fractions are Associated with Mean Compartmental Cavity Volume in Cardiac Disease.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022

Same author

The Ratio of Diastolic and Systolic Arterial Pressure is Associated with Pulse Pressure.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022

Same author

Case report on the importance of longitudinal analysis of left ventricular end-systolic volume, rather than ejection fraction, in a heart transplant patient.

European heart journal. Case reports·2021

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Published on: November 24, 2016

Early reperfusion phenomena.

Guy R Heyndrickx¹

¹Cardiovascular Center, Aalst and the Department of Cardiovascular Physiology, University of Louvain Medical School, Brussels, Belgium. guy.heyndrickx@olvz-aalst.be

Seminars in Cardiothoracic and Vascular Anesthesia

|September 9, 2006

Summary

Ischemia-reperfusion injury in cardiology causes myocardial stunning and hibernation. Understanding molecular adaptations to reperfusion injury is key to developing new treatments.

Area of Science:

Cardiology
Molecular Biology
Pathophysiology

Background:

Ischemia-reperfusion (I/R) cycles are common in cardiology, leading to syndromes like myocardial stunning, hibernation, and preconditioning.
Distinguishing between ischemic and reperfusion damage is challenging.
Oxygen free radicals and altered calcium homeostasis are key factors in early reperfusion injury.

Purpose of the Study:

To explore the molecular and genomic adaptations occurring in stunned myocardium.
To understand the mechanisms underlying the no-reflow phenomenon after prolonged ischemia.
To identify potential therapeutic targets for mitigating reperfusion injury.

Main Methods:

Review of existing literature on ischemia-reperfusion injury.
Analysis of molecular and genetic changes in stunned myocardium.

More Related Videos

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

Published on: November 8, 2019

Related Experiment Videos

Last Updated: Jul 20, 2026

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Published on: November 24, 2016

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

Published on: November 8, 2019

Investigation of microvasculature and myocyte interactions in the no-reflow phenomenon.

Main Results:

Identified upregulation and downregulation of specific genes in stunned myocardium, suggesting adaptive survival mechanisms.
Highlighted the role of microvascular and myocyte lesions in the no-reflow phenomenon.
Emphasized the complexity of distinguishing ischemic from reperfusion damage.

Conclusions:

Further research into molecular and genomic adaptations to I/R injury is crucial.
Enhanced understanding will improve strategies for combating reperfusion injury.
Targeting molecular pathways may offer novel therapeutic approaches for cardiac protection.